Back to search

Article

AAV-Mediated <i>In Vivo</i> CAR Gene Therapy for Targeting Human T Cell Leukemia

2021-02-15

Abstract excerpt

Chimeric antigen receptor (CAR) T cell therapy is the most active field in immuno-oncology and brings substantial benefit to patients with B cell malignancies. However, the complex procedure for CAR T cell generation hampers its widespread applications. Here, we describe a novel approach in which human CAR T cells can be generated within the host upon injecting an Adeno-associated virus (AAV)vector carrying the CA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a64cbd78-7cef-5c83-8c4f-6fb3bac43c0c
DOI
10.1101/2021.02.15.431201
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AAV-Mediated <i>In Vivo</i> CAR Gene Therapy for Targeting Human T Cell LeukemiaDOI 10.1101/2021.02.15.431201
Select a neighboring publication to make it the new centre.